Heat Biologics Announces Planned Acquisition of Elusys Therapeutics

NEXT STORY
The Worldwide Veterinary Dermatology Drugs Industry is Expected to Reach $13.6 Billion by 2027
PREV STORY
Clearside Biomedical Announces Positive Safety Results from OASIS Phase 1/2a Clinical Trial of CLS-AX (axitinib injectable suspension) for the Treatment of Wet AMD
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

MediciNova Announces MN-001 (tipelukast) Abstract regarding Lipid Metabolism in NASH/NAFLD Accepted for Presentation at The Liver Meeting® 2021, the Annual Meeting of the American Association for the Study of Liver Diseases

author_avatar
NASDAQ Market News

Genocea Provides Fourth Quarter 2020 Corporate Update

author_avatar
NASDAQ Market News

Kelly Osbourne, Laurie Hernandez, Jordin Sparks and Jeannie Mai Host Celebrity Packed Event to Address Mental Wellness for Teens

author_avatar
NASDAQ Market News